Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|October 27, 2022
Mutational Landscape of Patients Referred for Elevated Hemoglobin LevelPratibha Bhai, Benjamin Chin-Yee, Victor Pope, et al.
Blood|July 20, 2002
Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factorDavid A Hess, Krysta D Levac, Francis N Karanu, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Cytometry. Part B, Clinical Cytometry|July 16, 2020
A multicenter study evaluation of the ClearLLab 10C panelsBenjamin D Hedley, Guoyan Cheng, Michael Keeney, et al.
Journal of General Internal Medicine|November 30, 2022
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) StudyBenjamin Chin-Yee, Pratibha Bhai, Ian Cheong, et al.
Molecular Diagnosis & Therapy|April 6, 2022
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid MalignanciesPratibha Bhai, Cyrus C Hsia, Laila C Schenkel, et al.
British Journal of Haematology|June 27, 2020
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndromeEri Kawata, Alejandro Lazo-Langner, Anargyros Xenocostas, et al.
International Journal of Laboratory Hematology|October 29, 2021
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?Eri Kawata, Benjamin D Hedley, Benjamin Chin-Yee, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2024
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort StudyAlexandra Hillyer, Anthony Quint, Artin Ghassemian, et al.
Pageof 7